A detailed history of Susquehanna International Group, LLP transactions in Chroma Dex Corp. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 71,409 shares of CDXC stock, worth $487,009. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,409
Previous 12,800 457.88%
Holding current value
$487,009
Previous $34,000 664.71%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.51 - $3.8 $179,236 - $271,354
71,409 New
71,409 $260,000
Q1 2024

May 07, 2024

BUY
$1.36 - $3.84 $344,377 - $972,360
253,219 Added 1545.53%
269,603 $938,000
Q4 2023

Feb 14, 2024

BUY
$1.28 - $1.6 $20,971 - $26,214
16,384 New
16,384 $23,000
Q1 2023

May 16, 2023

BUY
$1.48 - $2.19 $161,241 - $238,593
108,947 New
108,947 $166,000
Q3 2022

Nov 14, 2022

SELL
$1.19 - $2.06 $172,559 - $298,716
-145,008 Reduced 60.26%
95,620 $118,000
Q2 2022

Aug 15, 2022

BUY
$1.59 - $2.7 $315,459 - $535,685
198,402 Added 469.86%
240,628 $402,000
Q1 2022

May 16, 2022

SELL
$2.02 - $3.92 $5,623 - $10,913
-2,784 Reduced 6.19%
42,226 $104,000
Q4 2021

Feb 14, 2022

BUY
$3.74 - $6.7 $67,207 - $120,399
17,970 Added 66.46%
45,010 $168,000
Q3 2021

Nov 15, 2021

SELL
$6.05 - $10.41 $402,197 - $692,046
-66,479 Reduced 71.09%
27,040 $170,000
Q2 2021

Aug 11, 2021

SELL
$6.66 - $10.92 $1.71 Million - $2.81 Million
-257,292 Reduced 73.34%
93,519 $922,000
Q1 2021

May 17, 2021

BUY
$4.59 - $18.74 $1.49 Million - $6.08 Million
324,679 Added 1242.46%
350,811 $3.28 Million
Q4 2020

Feb 16, 2021

BUY
$3.93 - $5.5 $34,937 - $48,895
8,890 Added 51.56%
26,132 $125,000
Q3 2020

Nov 16, 2020

SELL
$4.01 - $5.56 $45,585 - $63,206
-11,368 Reduced 39.73%
17,242 $69,000
Q2 2020

Aug 14, 2020

BUY
$3.0 - $5.52 $47,076 - $86,619
15,692 Added 121.47%
28,610 $131,000
Q1 2020

May 15, 2020

SELL
$2.54 - $4.75 $39,502 - $73,872
-15,552 Reduced 54.63%
12,918 $42,000
Q3 2019

Nov 14, 2019

BUY
$3.83 - $4.72 $23,742 - $29,259
6,199 Added 27.83%
28,470 $112,000
Q2 2019

Aug 16, 2019

BUY
$3.71 - $4.83 $18,345 - $23,884
4,945 Added 28.54%
22,271 $104,000
Q2 2019

Aug 14, 2019

BUY
$3.71 - $4.83 $64,279 - $83,684
17,326 New
17,326 $81,000
Q3 2018

Nov 14, 2018

SELL
$3.5 - $4.91 $52,101 - $73,090
-14,886 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$3.22 - $4.43 $654,152 - $899,967
-203,153 Reduced 93.17%
14,886 $55,000
Q1 2018

May 15, 2018

BUY
$4.05 - $6.46 $782,626 - $1.25 Million
193,241 Added 779.26%
218,039 $916,000
Q4 2017

Feb 14, 2018

SELL
$3.88 - $6.96 $31,676 - $56,821
-8,164 Reduced 24.77%
24,798 $146,000
Q3 2017

Nov 14, 2017

BUY
$2.91 - $4.71 $95,919 - $155,251
32,962
32,962 $142,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $466M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.